Our results point to PDGFRA as both the key pathogenesis driving receptor and the defining marker of the phenotype of an uninfected circulating KS progenitor (PDGFRA-positive bone marrow-derived MSCs), therefore intervening through the different steps of KSHV oncogenesis. This evidence concerns the gene PDGFRA and Kaposi's sarcoma.